Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Negrin

Showing results (111-120 of 163) with videos related to

Pageof 17
Sort By:
Blood|October 26, 2006
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemiaVivian G Oehler, Ted Gooley, David S Snyder, et al.
Nature Communications|May 10, 2017
Foxp3<sup>+</sup> regulatory T cells maintain the bone marrow microenvironment for B cell lymphopoiesisAntonio Pierini, Hidekazu Nishikii, Jeanette Baker, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2015
ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantationAaron C Logan, Zhiyu Wang, Kamran Alimoghaddam, et al.
Blood|December 2, 2004
Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell doseThai M Cao, Judith A Shizuru, Ruby M Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical studyJohn K Chan, Chad A Hamilton, Michael K Cheung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2011
Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantationGinna G Laport, Kevin Sheehan, Jeanette Baker, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Selective Immune Silencing by Targeted TGF-β AgonistsQinli Sun, Masato Ogishi, Hua Jiang, et al.
BMC Medicine|May 23, 2013
A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine modelCarina A Bäuerlein, Simone S Riedel, Jeanette Baker, et al.
Blood Advances|March 25, 2018
Infusion of donor-derived CD8<sup>+</sup> memory T cells for relapse following allogeneic hematopoietic cell transplantationLori Muffly, Kevin Sheehan, Randall Armstrong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2010
Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphomaSally Arai, Renee Letsinger, Ruby M Wong, et al.
Pageof 17

Showing results (111-120 of 163) with videos related to

Sort By:
Pageof 17
Blood|October 26, 2006
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemiaVivian G Oehler, Ted Gooley, David S Snyder, et al.
Nature Communications|May 10, 2017
Foxp3<sup>+</sup> regulatory T cells maintain the bone marrow microenvironment for B cell lymphopoiesisAntonio Pierini, Hidekazu Nishikii, Jeanette Baker, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2015
ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantationAaron C Logan, Zhiyu Wang, Kamran Alimoghaddam, et al.
Blood|December 2, 2004
Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell doseThai M Cao, Judith A Shizuru, Ruby M Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical studyJohn K Chan, Chad A Hamilton, Michael K Cheung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2011
Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantationGinna G Laport, Kevin Sheehan, Jeanette Baker, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Selective Immune Silencing by Targeted TGF-β AgonistsQinli Sun, Masato Ogishi, Hua Jiang, et al.
BMC Medicine|May 23, 2013
A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine modelCarina A Bäuerlein, Simone S Riedel, Jeanette Baker, et al.
Blood Advances|March 25, 2018
Infusion of donor-derived CD8<sup>+</sup> memory T cells for relapse following allogeneic hematopoietic cell transplantationLori Muffly, Kevin Sheehan, Randall Armstrong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2010
Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphomaSally Arai, Renee Letsinger, Ruby M Wong, et al.
Pageof 17